Traitement coronavirus guide - activities

Chloroquine: three authors of the study published in The Lancet are recanting

Chloroquine keeps on sparking off controversies within the international community… After a British study released in The Lancet said the treatment against coronavirus was useless, the medical magazine distanced tself with its results, now three authors are recanting. A study that convinced French Health Minister Olivier Véran this May 23 to review the regulations for prescribing this treatment.

Coronavirus: Anakinra, a promising treatment?

Is Anakinra an effective treatment against coronavirus? According to a French study released in The Lancet, the medicine usually prescribed for rheumatic diseases released encouraging results on severe Covid-19 forms. First results that will have to be confirmed on a greater number of patients.

Coronavirus: does chlorpromazine, medication against bipolarity, protect against COVID-19?

Medication against bipolarity, chlorpromazine could protect yourself against coronavirus. According to the Sainte-Anne University Hospital, patients treated with chlorpromazine are less hit by COVID-19 and symptomatic cases are rare. The Institut Pasteur has just launched a study.

Coronavirus: France exceptionnaly allows the use of plasma from cured patients

Trating patients with plasma from cured patients is finally authorized in France. Already used since April 7th, as part of clinical trials, plasma will be used to cure patients in a serious state, even though results are not guaranteed!

Coronavirus: towards medicines shortage in France?

Should France get ready to face medicines shortage? In an interview with Le Figaro, published on April 7, the Agence Nationale de Sécurité du Médicament or French Agency for the Safety of Medicine has said they only have a “fifteen-day” window of visibility for some products. Let’s have a look on the situation.